The impact of comorbidities on effect and discontinuation of tumour necrosis factor inhibitor therapy in psoriatic arthritis: a population-based cohort study

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Standard

The impact of comorbidities on effect and discontinuation of tumour necrosis factor inhibitor therapy in psoriatic arthritis : a population-based cohort study. / Ballegaard, C; Højgaard, P; Dreyer, Lene; Cordtz, R; Jørgensen, T S; Skougaard, M; Tarp, S; Kristensen, L E.

In: Annals of the Rheumatic Diseases, Vol. 76, No. Suppl 2, OP0106, 2017, p. 1.

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Harvard

Ballegaard, C, Højgaard, P, Dreyer, L, Cordtz, R, Jørgensen, TS, Skougaard, M, Tarp, S & Kristensen, LE 2017, 'The impact of comorbidities on effect and discontinuation of tumour necrosis factor inhibitor therapy in psoriatic arthritis: a population-based cohort study', Annals of the Rheumatic Diseases, vol. 76, no. Suppl 2, OP0106, pp. 1. <http://ard.bmj.com/content/76/Suppl_2/96.1.citation-tools>

APA

Ballegaard, C., Højgaard, P., Dreyer, L., Cordtz, R., Jørgensen, T. S., Skougaard, M., Tarp, S., & Kristensen, L. E. (2017). The impact of comorbidities on effect and discontinuation of tumour necrosis factor inhibitor therapy in psoriatic arthritis: a population-based cohort study. Annals of the Rheumatic Diseases, 76(Suppl 2), 1. [OP0106]. http://ard.bmj.com/content/76/Suppl_2/96.1.citation-tools

Vancouver

Ballegaard C, Højgaard P, Dreyer L, Cordtz R, Jørgensen TS, Skougaard M et al. The impact of comorbidities on effect and discontinuation of tumour necrosis factor inhibitor therapy in psoriatic arthritis: a population-based cohort study. Annals of the Rheumatic Diseases. 2017;76(Suppl 2):1. OP0106.

Author

Ballegaard, C ; Højgaard, P ; Dreyer, Lene ; Cordtz, R ; Jørgensen, T S ; Skougaard, M ; Tarp, S ; Kristensen, L E. / The impact of comorbidities on effect and discontinuation of tumour necrosis factor inhibitor therapy in psoriatic arthritis : a population-based cohort study. In: Annals of the Rheumatic Diseases. 2017 ; Vol. 76, No. Suppl 2. pp. 1.

Bibtex

@article{e062b75c9cac4f3c84542eaeca1172a3,
title = "The impact of comorbidities on effect and discontinuation of tumour necrosis factor inhibitor therapy in psoriatic arthritis: a population-based cohort study",
author = "C Ballegaard and P H{\o}jgaard and Lene Dreyer and R Cordtz and J{\o}rgensen, {T S} and M Skougaard and S Tarp and Kristensen, {L E}",
year = "2017",
language = "English",
volume = "76",
pages = "1",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "B M J Group",
number = "Suppl 2",

}

RIS

TY - ABST

T1 - The impact of comorbidities on effect and discontinuation of tumour necrosis factor inhibitor therapy in psoriatic arthritis

T2 - a population-based cohort study

AU - Ballegaard, C

AU - Højgaard, P

AU - Dreyer, Lene

AU - Cordtz, R

AU - Jørgensen, T S

AU - Skougaard, M

AU - Tarp, S

AU - Kristensen, L E

PY - 2017

Y1 - 2017

M3 - Conference abstract in journal

VL - 76

SP - 1

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - Suppl 2

M1 - OP0106

ER -

ID: 194044805